Monday, December 23, 2024
HomeTagsJapan & LONDON

Japan & LONDON

Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors

Takeda Pharmaceutical Company Limited (“Takeda”) announced the exercise of its option to acquire Adaptate Biotherapeutics (“Adaptate”), a UK company focused on developing antibody-based therapeutics...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics